You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》來凱醫藥(02105.HK)暗盤高開5.4%報13.08元
阿思達克 06-28 16:18
根據輝立交易平台顯示,明天掛牌的來凱醫藥-B(02105.HK)暗盤高開5.4%報13.08元獲承接,最高見16元遇壓,現報13.6元,較上市價12.41元,高9.6%,成交7.5萬股。 來凱醫藥是一家以科學為驅動、處於臨床階段的生物醫藥科技商。公司擁有獲諾華授權引進用於治療癌症的兩款核心產品LAE002和LAE001,以及14種其他管線候選產品。是次在港上市以每股12.41元合共發售6,372.8萬股,並已引入包括余姚、先進製造產業投資基金二期(FIIF)、燕創宸凱及OrbiMed四名基石投資者,合共認購5,480.65萬股。佔發售股份10%的公開發售獲4.8倍超購,認購一手中籤率22.3%,料淨籌約7.08億元,主要用於推進兩款核心產品LAE001和LAE002的臨床開發及批准、加快其他現有管線產品研發、提高產能和發展製造能力,以及用於業務發展活動及增強全球網絡等。上市獨家保薦人中金。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account